Hadasit Medical Research Services and Development Ltd.
发明人:
申请号：
EP16856304.7
公开号：
EP3362053A4
申请日:
2016.10.14
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Methods of treating patients suffering from non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), including those also suffering from type II diabetes mellitus (T2DM), with a delayed release pharmaceutical composition comprising 6-mercaptopurine are disclosed.
